Biotherapeutic development demands flexible and automated platforms that deliver accurate, replicable results at scale, from discovery to manufacture.
Resource articles
IMMUNOASSAYS
Using Automated Immunoassays for HCP Analysis in Early Bioprocess Development
PEPTIDES
From Lab to Scale: A Game-Changing Approach to Peptide Purification in GLP-1 Manufacturing
Discover how innovative PEC technology transforms GLP-1 peptide manufacturing, offering a cost-effective alternative to traditional purification methods.
IMMUNOASSAYS
White Paper: Increasing productivity in cell and gene therapy bioprocessing with fast and reliable immunoassays
Whitepaper on immunoassays used in viral vector bioprocessing, including Gyrolab case studies from cell & gene therapy labs
IMMUNOASSAYS
Article - Development of anti-AAV assay for detection of pre-existing AAV immunity
This article presents an assay to detect pre-existing AAV immunity of subjects in pre-clinical studies, aiding subject selection and improving gene therapy research efficiency.
IMMUNOASSAYS
AN: Accelerate throughput in therapeutic antibody development with an improved generic PK assay
This application note helps research scientists optimize preclinical pharmacokinetics studies by highlighting improved assay flexibility, sensitivity, and sample efficiency using the Gyrolab® 2G Generic PK Kit
IMMUNOASSAYS
White Paper: ADA — How to Maximize Drug Tolerance and Minimize Sample and Reagent Consumption
This White Paper demonstrates how the Gyrolab® platform enhances ADA analysis with automation, sensitivity, and minimal sample use.
IMMUNOASSAYS
AN: Selective and robust biomarker quantification using Gyrolab human cytokine kit reagents
This application note guides research scientists in using Gyrolab® single-analyte cytokine assays for fast, automated, and robust biomarker quantification. Detection of 5 human cytokines, IL-4, IL-6, IL-10, IFN-gamma, and TNF-alpha in single-analyte automated assays on the Gyrolab platform evaluating selectivity.